GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30210% above fair value
$237.31−0.79 (-0.33%)
Close on Nov 20, 2026Market cap $14.05BP/E –Yield –
Glaukos gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Glaukos's gross profit for the twelve months ending Sep 30, 2026 was $447.18M, up 23.8% year over year. For fiscal 2025 it was $282.76M, down 2.3% from the year before. Over ten years it grew 17.0% a year on average. The highest annual figure on record is $289.45M in fiscal 2024.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $282.76M | -2.3% |
| FY2024 | Dec 31, 2024 | $289.45M | +21.0% |
| FY2023 | Dec 31, 2023 | $239.14M | +11.8% |
| FY2022 | Dec 31, 2022 | $213.88M | -5.9% |
| FY2021 | Dec 31, 2021 | $227.38M | +70.7% |
| FY2020 | Dec 31, 2020 | $133.24M | -32.8% |
| FY2019 | Dec 31, 2019 | $198.40M | +27.0% |
| FY2018 | Dec 31, 2018 | $156.20M | +13.0% |
| FY2017 | Dec 31, 2017 | $138.20M | +40.7% |
| FY2016 | Dec 31, 2016 | $98.22M | +67.3% |
| FY2015 | Dec 31, 2015 | $58.71M | +71.8% |
| FY2014 | Dec 31, 2014 | $34.17M | +85.6% |
| FY2013 | Dec 31, 2013 | $18.41M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $179.87M | +71.8% |
| Q2 FY2026 | Jun 30, 2026 | $151.59M | +55.9% |
| Q1 FY2026 | Mar 31, 2026 | $117.23M | +42.4% |
| Q4 FY2025 | Dec 31, 2025 | -$1.52M | -102.0% |
| Q3 FY2025 | Sep 30, 2025 | $104.71M | +41.3% |
| Q2 FY2025 | Jun 30, 2025 | $97.22M | +32.9% |
| Q1 FY2025 | Mar 31, 2025 | $82.35M | +26.0% |
| Q4 FY2024 | Dec 31, 2024 | $76.86M | +21.1% |
| Q3 FY2024 | Sep 30, 2024 | $74.09M | +24.4% |
| Q2 FY2024 | Jun 30, 2024 | $73.14M | +21.3% |
| Q1 FY2024 | Mar 31, 2024 | $65.36M | +17.1% |
| Q4 FY2023 | Dec 31, 2023 | $63.47M | +17.5% |
| Q3 FY2023 | Sep 30, 2023 | $59.54M | +9.4% |
| Q2 FY2023 | Jun 30, 2023 | $60.30M | +9.9% |
| Q1 FY2023 | Mar 31, 2023 | $55.83M | +10.3% |
| Q4 FY2022 | Dec 31, 2022 | $54.01M | -4.2% |
| Q3 FY2022 | Sep 30, 2022 | $54.41M | -8.3% |
| Q2 FY2022 | Jun 30, 2022 | $54.85M | -9.1% |
| Q1 FY2022 | Mar 31, 2022 | $50.62M | -1.4% |
| Q4 FY2021 | Dec 31, 2021 | $56.38M | +5.1% |
| Q3 FY2021 | Sep 30, 2021 | $59.34M | +26.5% |
| Q2 FY2021 | Jun 30, 2021 | $60.33M | +510.1% |
| Q1 FY2021 | Mar 31, 2021 | $51.34M | +125.1% |
| Q4 FY2020 | Dec 31, 2020 | $53.64M | +7.4% |
| Q3 FY2020 | Sep 30, 2020 | $46.90M | -7.7% |
| Q2 FY2020 | Jun 30, 2020 | $9.89M | -80.5% |
| Q1 FY2020 | Mar 31, 2020 | $22.81M | -51.4% |
| Q4 FY2019 | Dec 31, 2019 | $49.95M | +6.4% |
| Q3 FY2019 | Sep 30, 2019 | $50.81M | +34.1% |
| Q2 FY2019 | Jun 30, 2019 | $50.73M | +37.1% |
| Q1 FY2019 | Mar 31, 2019 | $46.92M | +36.6% |
| Q4 FY2018 | Dec 31, 2018 | $46.96M | +26.8% |
| Q3 FY2018 | Sep 30, 2018 | $37.90M | +9.2% |
| Q2 FY2018 | Jun 30, 2018 | $37.00M | +3.5% |
| Q1 FY2018 | Mar 31, 2018 | $34.35M | +11.8% |
| Q4 FY2017 | Dec 31, 2017 | $37.02M | +30.5% |
| Q3 FY2017 | Sep 30, 2017 | $34.69M | – |
| Q2 FY2017 | Jun 30, 2017 | $35.76M | – |
| Q1 FY2017 | Mar 31, 2017 | $30.73M | – |
| Q4 FY2016 | Dec 31, 2016 | $28.36M | – |
See a number that looks wrong?